Natural history of eosinophilic esophagitis in adults and children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-phase, multicenter prospective observational study of eosinophilic esophagitis. In phase one, researchers will validate the Italian version of the Dysphagia Symptom Questionnaire. In phase two, they will explore clinical outcomes in EoE patients, with participants from phase one able to join. Optional serum and esophageal tissue samples will be collected for exploratory analyses in eligible participants. The study aims to map natural history and assess how symptoms and disease progression unfold in both adult and pediatric patients over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients with an established diagnosis of Eosinophilic esophagitis;
* aged ≥5 years;
* who gave written informed consent.

Exclusion Criteria:

* under 5 years old;
* Patients who are illiterate;
* Patients who are unwilling to participate

Where it's running

• Fondazione IRCCS Policlinico San Matteo di Pavia
  Pavia, Pavia, Italy Recruiting
• S. C. General Medicine I, Fondazione IRCCS Policlinico San MAtteo
  Pavia, Pavia, Italy Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of Patient Position on EndoFLIP Measurements in Kids and Young Adults

  This study tests whether EndoFLIP measurements differ when patients are in the supine versus left-side position during the procedure.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07780981

• Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy

  This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.

  Recruiting Phase 2 University of North Carolina, Chapel Hill · Chapel Hill, North Carolina and 1 other locations · NCT07588568

• Partial enteral nutrition with a dairy-free diet for eosinophilic esophagitis

  This study tests whether partial enteral nutrition plus a dairy-free diet can bring remission and change immune responses, gut bacteria, and toxin levels in children and young adults with eosinophilic esophagitis.

  Recruiting Kate Farms Inc · Seattle, Washington · NCT07234825

• Dupilumab for young children with eosinophilic esophagitis (food-pipe inflammation)

  This study will test whether 24 weeks of dupilumab helps infants and toddlers with active eosinophilic esophagitis improve feeding and reduce esophageal inflammation.

  Recruiting at 13 sites Phase 3 Regeneron Pharmaceuticals · Phoenix, Arizona and 12 other locations · NCT07112378

• Local immune and barrier changes in eosinophilic esophagitis

  This study tests whether esophageal barrier problems and type 2 inflammation differ in adults with EoE (including those starting dupilumab or topical budesonide) compared with people without EoE.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT07012928

• Effect of Dupilumab on Esophageal Muscle Function in Eosinophilic Esophagitis

  This study is testing if Dupilumab can help improve the muscle function in the esophagus of people with Eosinophilic Esophagitis.

  Recruiting Phase 4 University of California, San Diego · La Jolla, California · NCT06665971

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.